Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells

  • Authors:
    • Huannan Li
    • Xiaoren Cao
    • Xiongbing Chen
    • Xiaohong Yi
    • Jun Xia
    • Jilan Chen
    • Lan Yang
  • View Affiliations

  • Published online on: July 1, 2019     https://doi.org/10.3892/mmr.2019.10452
  • Pages: 2347-2354
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The purpose of the present study was to investigate the effect of bufadienolides on the A‑375 melanoma cell line, and to delineate the underlying mechanism. A Cell Counting Kit‑8 assay was used to determine the viability of the cells, and flow cytometry was used to evaluate apoptosis. Western blot analysis was used to evaluate the expression levels of proteins involved in the AKT pathway that are associated with apoptosis and autophagy. The results demonstrated that bufadienolides reduced the viability of A‑375 cells in a dose‑ and a time‑dependent manner. Following treatment with bufadienolides, A‑375 cells exhibited clear properties that were characteristic of apoptosis and autophagy. The expression levels of the pro‑apoptotic proteins Bax and p53 were upregulated, whereas those of the anti‑apoptotic proteins, Bcl‑2 and caspase‑3 were downregulated. In addition, the level of a protein known to be associated with autophagy, microtubule‑associated proteins 1A/1B light chain 3‑II, was increased, whereas that of p62 protein was reduced. Finally, the AKT signaling pathway was blocked in the bufadienolide‑treated A‑375 cells. In conclusion, these results revealed that bufadienolides effectively induced apoptosis and autophagy in A‑375 cells via the AKT pathway, and therefore may be one of the candidate targets for the future development of targeted drugs to treat melanoma.

References

1 

Dountsis A, Zsis C, Karagianni E and Dahabreh J: Primary malignant melanoma of the lung: A case report. World J Surg Oncol. 1:26–29. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Wang Q, Zhang R and Liu D: Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p. Exp Ther Med. 17:857–862. 2019.PubMed/NCBI

3 

Slominski A, Tobin DJ, Shibahara S and Wortsman J: Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 84:1155–1228. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Chang L, Pei J, Li C, Zhang P, Zhou D, Du W, Liu X and Jiang C: Incidence and metastasis of cutaneous malignant melanoma with respect to ABO blood groups: A case-controlled study in northeast of China. PLoS One. 9:e880962014. View Article : Google Scholar : PubMed/NCBI

5 

Sample A and He YY: Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed. 34:13–24. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Khan AQ, Travers JB and Kemp MG: Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Environ Mol Mutagen. 59:438–460. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Miura K and Green AC: Dietary Antioxidants and Melanoma: Evidence from Cohort and Intervention Studies. Nutr Cancer. 67:867–876. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Lee SJ, Lee KB, Son YH, Shin J, Lee JH, Kim HJ, Hong AY, Bae HW, Kwon MA, Lee WJ, et al: Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production. Cell Death Dis. 8:e31482017. View Article : Google Scholar : PubMed/NCBI

9 

Slominski AT, Brozyna AA, Zmijewski MA, Jóźwicki W, Jetten AM, Mason RS, Tuckey RC and Elmets CA: Vitamin D signaling and melanoma: Role of vitamin D and its receptors in melanoma progression and management. Lab Invest. 97:706–724. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Xiao D, Barry S, Kmetz D, Egger M, Pan J, Rai SN, Qu J, McMasters KM and Hao H: Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. Cancer Lett. 376:318–327. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Giavina-Bianchi MH, Giavina-Bianchi PF Junior and Festa C Neto: Melanoma: Tumor microenvironment and new treatments. An Bras Dermatol. 92:156–166. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Slominski AT and Carlson JA: Melanoma resistance: A bright future for academicians and a challenge for patient advocates. Mayo Clin Proc. 89:429–433. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M and Fitzmaurice C: The global burden of melanoma: Results from the Global burden of disease study 2015. Br J Dermatol. 177:134–140. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Whiteman DC, Green AC and Olsen CM: The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 136:1161–1171. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Kim JS, Jeong TY, Cho CK, Lee YW and Yoo HS: Antitumor effect of skin of venenum bufonis in a NCIH460 tumor regression model. J Acupunct Meridian Stud. 3:181–187. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Deng LJ, Wang LH, Peng CK, Li YB, Huang MH, Chen MF, Lei XP, Qi M, Cen Y, Ye WC, et al: Fibroblast activation protein α activated tripeptide bufadienolide antitumor prodrug with reduced cardiotoxicity. J Med Chem. 60:5320–5333. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Chang H, Li J, Cao Y, Liu T, Shi S and Chen W: Bufadienolides from venenum bufonis inhibit mTOR-mediated cyclin D1 and retinoblastoma protein leading to arrest of cell cycle in cancer cells. Evid Based Complement Alternat Med. 2018:32474022018. View Article : Google Scholar : PubMed/NCBI

18 

Amaral LS, Martins Ferreira J, Predes D, Abreu JG, Noël F and Quintas LEM: Telocinobufagin and marinobufagin produce different effects in LLC-PK1 cells: A case of functional selectivity of bufadienolides. Int J Mol Sci. 19(pii): E27692018. View Article : Google Scholar : PubMed/NCBI

19 

Sheng X, Zhu P, Qin J and Li Q: The biological role of autophagy in regulating and controlling the proliferation of liver cancer cells induced by bufalin. Oncol Rep. 39:2931–2941. 2018.PubMed/NCBI

20 

Liu M, Feng LX, Sun P, Liu W, Wu WY, Jiang BH, Yang M, Hu LH, Guo DA and Liu X: A novel bufalin derivative exhibited stronger apoptosis-inducing effect than bufalin in A549 lung cancer cells and lower acute toxicity in mice. PLoS One. 11:e01597892016. View Article : Google Scholar : PubMed/NCBI

21 

Zhang H, Zhang X and Zhang J: MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14. Biochem Biophys Res Commun. 506:272–277. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Meng Q, Yau LF, Lu JG, Wu ZZ, Zhang BX, Wang JR and Jiang ZH: Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin. J Ethnopharmacol. 187:74–82. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Berger MF and Garraway LA: Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am. 23:397–414. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Cui Y, Zhang Z, Zhang B, Zhao L, Hou C, Zeng Q, Nie J, Yu J, Zhao Y, Gao T, et al: Excessive apoptosis and disordered autophagy flux contribute to the neurotoxicity induced by high iodine in Sprague-Dawley rat. Toxicol Lett. 297:24–33. 2018. View Article : Google Scholar : PubMed/NCBI

25 

Chou HY, Chueh FS, Ma YS, Wu RS, Liao CL, Chu YL, Fan MJ, Huang WW and Chung JG: Bufalin induced apoptosis in SCC-4 human tongue cancer cells by decreasing Bcl-2 and increasing Bax expression via the mitochondria-dependent pathway. Mol Med Rep. 16:7959–7966. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Zaman S, Wang R and Gandhi V: Targeting the apoptosis pathway in hematologic malignancies. Leuk Lymphoma. 55:1980–1992. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Yun CW and Lee SH: The roles of autophagy in cancer. Int J Mol Sci. 19(pii): E34662018. View Article : Google Scholar : PubMed/NCBI

28 

Radogna F, Dicato M and Diederich M: Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target. Biochem Pharmacol. 94:1–11. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Jena KK, Kolapalli SP, Mehto S, Nath P, Das B, Sahoo PK, Ahad A, Syed GH, Raghav SK, Senapati S, et al: TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy. EMBO J. 37(pii): e983582018.PubMed/NCBI

30 

Niklaus M, Adams O, Berezowska S, Zlobec I, Graber F, Slotta-Huspenina J, Nitsche U, Rosenberg R, Tschan MP and Langer R: Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer. Oncotarget. 8:54604–54615. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Sophia J, Kowshik J, Dwivedi A, Bhutia SK, Manavathi B, Mishra R and Nagini S: Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer. Cell Death Dis. 9:10872018. View Article : Google Scholar : PubMed/NCBI

32 

Sun YZ, Cai N and Liu NN: Celecoxib down-regulates the hypoxia-induced expression of HIF-1α and VEGF through the PI3K/AKT pathway in retinal pigment epithelial cells. Cell Physiol Biochem. 44:1640–1650. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Feng H, Cheng X, Kuang J, Chen L, Yuen S, Shi M, Liang J, Shen B, Jin Z, Yan J and Qiu W: Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer. Cell Death Dis. 9:10302018. View Article : Google Scholar : PubMed/NCBI

34 

Fan YP, Liu P, Xue WK, Zhao WJ and Pan HC: Trimebutine promotes Glioma cell apoptosis as a potential anti-tumor agent. Front Pharmacol Front Pharmacol. 9:6642018. View Article : Google Scholar : PubMed/NCBI

35 

Shen S, Zhang Y, Wang Z, Liu R and Gong X: Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci. 10:212–224. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX and Ye WC: Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis. 34:1331–1342. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Kim SJ, Kim JH, Jung HS, Lee TJ, Lee KM and Chang IH: Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: Correlation with tumor recurrence. Asian J Androl. 16:611–617. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Kaidanovich-Beilin O and Woodgett JR: GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci. 4:402011. View Article : Google Scholar : PubMed/NCBI

39 

Wang Q, Zheng M, Yin Y and Zhang W: Ghrelin stimulates hepatocyte proliferation via regulating cell cycle through GSK3β/B-catenin signaling pathway. Cell Physiol Biochem. 50:1698–1710. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, H., Cao, X., Chen, X., Yi, X., Xia, J., Chen, J., & Yang, L. (2019). Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells. Molecular Medicine Reports, 20, 2347-2354. https://doi.org/10.3892/mmr.2019.10452
MLA
Li, H., Cao, X., Chen, X., Yi, X., Xia, J., Chen, J., Yang, L."Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells". Molecular Medicine Reports 20.3 (2019): 2347-2354.
Chicago
Li, H., Cao, X., Chen, X., Yi, X., Xia, J., Chen, J., Yang, L."Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells". Molecular Medicine Reports 20, no. 3 (2019): 2347-2354. https://doi.org/10.3892/mmr.2019.10452